Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 16Unknown 2Active not recruiting 2Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 15Gastrointestinal 7Genitourinary 6Endocrine 6Tumor-Agnostic 4Head & Neck 3Sarcoma 2Other solid neoplasm 2Other hematologic neoplasm 2NET 2Thoracic 1Other neoplasm 1Lymphoid 1Gynecologic 1Dermatologic 1CNS 1

Conditions

Relapsed Pediatric Solid Tumor 1Advanced Solid Tumors 1

Interventions

Injections 17Cisplatin 15Carboplatin 15Oxaliplatin 11Gemcitabine 11pembrolizumab 8Capecitabine 8toripalimab 7Paclitaxel 7Etoposide 7Cyclophosphamide 7Pemetrexed 6Irinotecan 6Drug Therapy 6spartalizumab 5fludarabine 5camrelizumab 5Vincristine 5Radiotherapy 5Leucovorin 5tislelizumab 4apatinib 4anlotinib 4Interleukin-2 4Immune Checkpoint Inhibitors 4Granulocyte-Macrophage Colony-Stimulating Factor 4Fluorouracil 4Docetaxel 4Bevacizumab 4tremelimumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Everolimus × Other solid neoplasm × Clear all
NCT02638428 2020-03-19

Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy

Samsung Medical Center

Phase 2 Unknown
90 enrolled
Other solid neoplasm

Relapsed Pediatric Solid Tumor

NCT01148628 2011-09-13

Dose-finding Study of CAELYXTM and RAD001 in Patients With Advanced Solid Tumors

Southern Europe New Drug Organization

Phase 1 Unknown
54 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡